This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, N.
Right arrow Articles by Paterson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, N.
Right arrow Articles by Paterson, D. L.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, January 2005, p. 44-69, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.44-69.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Aspergillus Infections in Transplant Recipients

Nina Singh* and David L. Paterson

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

Aspergillus infections are occurring with an increasing frequency in transplant recipients. Notable changes in the epidemiologic characteristics of this infection have occurred; these include a change in risk factors and later onset of infection. Management of invasive aspergillosis continues to be challenging, and the mortality rate, despite the use of newer antifungal agents, remains unacceptably high. Performing molecular studies to discern new targets for antifungal activity, identifying signaling pathways that may be amenable to immunologic interventions, assessing combination regimens of antifungal agents or combining antifungal agents with modulation of the host defense mechanisms, and devising diagnostic assays that can rapidly and reliably diagnose infections represent areas for future investigations that may lead to further improvement in outcomes.

* Corresponding author. Mailing address: VA Medical Center, Infectious Disease Section, University Dr. C, Pittsburgh, PA 15240. Phone: (412) 688-6179. Fax: (412) 688-6950. E-mail: nis5+{at}pitt.edu.

Clinical Microbiology Reviews, January 2005, p. 44-69, Vol. 18, No. 1
0893-8512/05/$08.00+0     doi:10.1128/CMR.18.1.44-69.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cannon, R. D., Lamping, E., Holmes, A. R., Niimi, K., Baret, P. V., Keniya, M. V., Tanabe, K., Niimi, M., Goffeau, A., Monk, B. C. (2009). Efflux-Mediated Antifungal Drug Resistance. Clin. Microbiol. Rev. 22: 291-321 [Abstract] [Full Text]  
  • Nicasio, A. M., Tessier, P. R., Nicolau, D. P., Knauft, R. F., Russomanno, J., Shore, E., Kuti, J. L. (2009). Bronchopulmonary Disposition of Micafungin in Healthy Adult Volunteers. Antimicrob. Agents Chemother. 53: 1218-1220 [Abstract] [Full Text]  
  • Montenegro, G., Sanchez Puch, S., Jewtuchowicz, V. M., Pinoni, M. V., Relloso, S., Temporitti, E., Iovannitti, C. A., Mujica, M. T. (2009). Phenotypic and genotypic characterization of Aspergillus lentulus and Aspergillus fumigatus isolates in a patient with probable invasive aspergillosis. J Med Microbiol 58: 391-395 [Abstract] [Full Text]  
  • Cowen, L. E., Singh, S. D., Kohler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., Lindquist, S. (2009). Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc. Natl. Acad. Sci. USA 106: 2818-2823 [Abstract] [Full Text]  
  • Husain, S., Clancy, C. J., Nguyen, M. H., Swartzentruber, S., Leather, H., LeMonte, A. M., Durkin, M. M., Knox, K. S., Hage, C. A., Bentsen, C., Singh, N., Wingard, J. R., Wheat, L. J. (2008). Performance Characteristics of the Platelia Aspergillus Enzyme Immunoassay for Detection of Aspergillus Galactomannan Antigen in Bronchoalveolar Lavage Fluid. CVI 15: 1760-1763 [Abstract] [Full Text]  
  • Brock, M., Jouvion, G., Droin-Bergere, S., Dussurget, O., Nicola, M.-A., Ibrahim-Granet, O. (2008). Bioluminescent Aspergillus fumigatus, a New Tool for Drug Efficiency Testing and In Vivo Monitoring of Invasive Aspergillosis. Appl. Environ. Microbiol. 74: 7023-7035 [Abstract] [Full Text]  
  • Cramer, R. A. Jr., Perfect, B. Z., Pinchai, N., Park, S., Perlin, D. S., Asfaw, Y. G., Heitman, J., Perfect, J. R., Steinbach, W. J. (2008). Calcineurin Target CrzA Regulates Conidial Germination, Hyphal Growth, and Pathogenesis of Aspergillus fumigatus. Eukaryot Cell 7: 1085-1097 [Abstract] [Full Text]  
  • Hansen, D., Healy, M., Reece, K., Smith, C., Woods, G. L. (2008). Repetitive-Sequence-Based PCR Using the DiversiLab System for Identification of Aspergillus Species. J. Clin. Microbiol. 46: 1835-1839 [Abstract] [Full Text]  
  • Burgos, A., Zaoutis, T. E., Dvorak, C. C., Hoffman, J. A., Knapp, K. M., Nania, J. J., Prasad, P., Steinbach, W. J. (2008). Pediatric Invasive Aspergillosis: A Multicenter Retrospective Analysis of 139 Contemporary Cases. Pediatrics 121: e1286-e1294 [Abstract] [Full Text]  
  • Mennink-Kersten, M. A. S. H., Ruegebrink, D., Klont, R. R., Warris, A., Blijlevens, N. M. A., Donnelly, J. P., Verweij, P. E. (2008). Improved Detection of Circulating Aspergillus Antigen by Use of a Modified Pretreatment Procedure. J. Clin. Microbiol. 46: 1391-1397 [Abstract] [Full Text]  
  • Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M., Nguyen, M. H. (2007). Bronchoalveolar Lavage Galactomannan in Diagnosis of Invasive Pulmonary Aspergillosis among Solid-Organ Transplant Recipients. J. Clin. Microbiol. 45: 1759-1765 [Abstract] [Full Text]  
  • (2007). Tender Erythema of the Left Lower Extremity--Diagnosis. Arch Dermatol 143: 535-540 [Full Text]  
  • Khan, Z. U., Ahmad, S., Mokaddas, E., Said, T., Nair, M. P., Halim, M. A., Nampoory, M. R., McGinnis, M. R. (2007). Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1->3)-{beta}-D-glucan in clinical specimens. J Med Microbiol 56: 129-132 [Abstract] [Full Text]  
  • Griffiths, L. J., Anyim, M., Doffman, S. R., Wilks, M., Millar, M. R., Agrawal, S. G. (2006). Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR.. J Med Microbiol 55: 1187-1191 [Abstract] [Full Text]  
  • Capitano, B., Potoski, B. A., Husain, S., Zhang, S., Paterson, D. L., Studer, S. M., McCurry, K. R., Venkataramanan, R. (2006). Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen.. Antimicrob. Agents Chemother. 50: 1878-1880 [Abstract] [Full Text]  
  • Lopez-Oviedo, E., Aller, A. I., Martin, C., Castro, C., Ramirez, M., Peman, J. M., Canton, E., Almeida, C., Martin-Mazuelos, E. (2006). Evaluation of Disk Diffusion Method for Determining Posaconazole Susceptibility of Filamentous Fungi: Comparison with CLSI Broth Microdilution Method. Antimicrob. Agents Chemother. 50: 1108-1111 [Abstract] [Full Text]  
  • Pickering, J. W., Sant, H. W., Bowles, C. A. P., Roberts, W. L., Woods, G. L. (2005). Evaluation of a (1->3)-{beta}-D-Glucan Assay for Diagnosis of Invasive Fungal Infections. J. Clin. Microbiol. 43: 5957-5962 [Abstract] [Full Text]  
  • Bart-Delabesse, E., Basile, M., Al Jijakli, A., Souville, D., Gay, F., Philippe, B., Bossi, P., Danis, M., Vernant, J.-P., Datry, A. (2005). Detection of Aspergillus Galactomannan Antigenemia To Determine Biological and Clinical Implications of Beta-Lactam Treatments. J. Clin. Microbiol. 43: 5214-5220 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»